Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AAK1 | Q2M2I8 | 2/20 | 0.50 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.49 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.45 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.45 |
| ▸ | CTSS | P25774 | 6/20 | 0.45 |
| ▸ | CTSK | P43235 | 5/20 | 0.45 |
| ▸ | CTSL | P07711 | 1/20 | 0.44 |
| ▸ | CTSB | P07858 | 1/20 | 0.44 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.43 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.43 |
| ▸ | ACE | P12821 | 1/20 | 0.43 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
| ▸ | F11 | P03951 | 1/20 | 0.43 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.43 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.43 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30400176 | 1.00 | AAK1 (0.50) | AAK1KLK5ITGB3ITGA2BCTSS | |
| SCHEMBL539840 | 1.00 | AAK1 (0.50) | AAK1KLK5ITGB3ITGA2BCTSS | |
| SCHEMBL15615749 | 0.97 | CTSS (0.49) | AAK1KLK5ITGB3ITGA2BCTSS | |
| SCHEMBL16934587 | 0.97 | CTSS (0.49) | AAK1KLK5ITGB3ITGA2BCTSS | |
| SCHEMBL17459580 | 0.94 | AAK1 (0.51) | AAK1KLK5ITGB3ITGA2BCTSS | |
| SCHEMBL21732913 | 0.94 | AAK1 (0.51) | AAK1KLK5ITGB3ITGA2BCTSS | |
| SCHEMBL17459578 | 0.94 | AAK1 (0.51) | AAK1KLK5ITGB3ITGA2BCTSS | |
| SCHEMBL23419294 | 0.91 | AAK1 (0.48) | AAK1KLK5ITGB3ITGA2BCTSS | |
| SCHEMBL7230674 | 0.91 | AAK1 (0.48) | AAK1KLK5ITGB3ITGA2BCTSS | |
| SCHEMBL16469777 | 0.90 | AAK1 (0.50) | AAK1KLK5ITGB3ITGA2BCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250381168-A1 | VLA4 INHIBITORS AND USES THEREOF | WASHINGTON UNIVERSITY ST LOUIS (US) | 2025-12-18 | — | — | US | disclosed |
| WO-2023250339-A2 | VLA4 INHIBITORS AND USES THEREOF | WASHINGTON UNIVERSITY (US) | 2023-12-28 | — | — | WO | disclosed |
| WO-2023239925-A1 | CYCLOPHILIN INHIBITORS AND USES THEREOF | THE BROAD INSTITUTE, INC. (US) | 2023-12-14 | — | — | WO | disclosed |
| US-20230348483-A1 | PREPARATION METHOD FOR (S)-2-AMINO-3-(4-(2,3-DIMETHYLPYRIDIN-4-YL)PHENYL)METHYL PROPIONATE DIACID SALT | Hangzhou zhongmei huadong pharmaceutical co ltd (CN) | 2023-11-02 | — | — | US | disclosed |
| US-20230348483-A1 | PREPARATION METHOD FOR (S)-2-AMINO-3-(4-(2,3-DIMETHYLPYRIDIN-4-YL)PHENYL)METHYL PROPIONATE DIACID SALT | Hangzhou zhongmei huadong pharmaceutical co ltd (CN) | 2023-11-02 | — | — | US | disclosed |
| US-20230348390-A1 | METHOD FOR PREPARING METHYL(S)-2-AMINO-3-(4-(2,3-DIMETHYLPYRIDIN-4-YL)PHENYLPROPIONATE AND SALT THEREOF | Hangzhou zhongmei huadong pharmaceutical co ltd (CN) | 2023-11-02 | — | — | US | disclosed |
| US-20230072397-A1 | Antimicrobial Compounds and Methods | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-03-09 | — | — | US | disclosed |
| CN-115667219-A | Preparation method of (S) -2-amino-3- (4- (2,3-dimethylpyridine-4-yl) phenyl) methyl propionate diacid salt | 杭州中美华东制药有限公司 | 2023-01-31 | — | — | CN | disclosed |
| WO-2021242807-A1 | METHODS FOR PREPARING METHYL (S)-2-AMINO-3-(4-(2,3-DIMETHYLPYRIDIN-4-YL)PHENYL)PROPIONATE AND HYDROCHLORIC ACID SALTS THEREOF | VTV THERAPEUTICS LLC (US) | 2021-12-02 | — | — | WO | disclosed |
| CN-109053723-B | Sulfonamide derivatives and pharmaceutical use thereof | EA制药株式会社 | 2021-09-03 | — | — | CN | disclosed |
| WO-2009042733-A1 | SOLIDS FORMS OF ( S) -ETHYL 2-AMIN0-3- (4- (2 -AMINO- 6- ( (R) -1- (4-CHL0R0-2- O-METHYL-IH-PYRAZOL- 1-YL) PHENYL) -2, 2, 2-TRIFLUORETHOXY) -PYRIMIDIN-4-YL) PHENYL) PROPANOATE | LEXICON PHARMACEUTICALS, INC. (US) | 2009-04-02 | — | — | WO | disclosed |
| US-20090088447-A1 | SOLID FORMS OF (S)-ETHYL 2-AMINO-3-(4-(2-AMINO-6-((R)-1-(4-CHLORO-2-(3-METHYL-1H-PYRAZOL-1-YL)PHENYL)-2,2,2-TRIFLUOROETHOXY)-PYRIMIDIN-4-YL)PHENYL)PROPANOATE AND METHODS OF THEIR USE | TERSERA THERAPEUTICS LLC | 2009-04-02 | — | — | US | disclosed |
| WO-2009029499-A1 | METHODS OF PREPARING 4-PHENYL-6-(2,2,2-TRIFLUORO-1-PHENYLETHOXY)PYRIMIDINE-BASED COMPOUNDS | LEXICON PHARMACEUTICALS, INC. (US) | 2009-03-05 | — | — | WO | disclosed |
| US-20090062540-A1 | METHODS OF PREPARING 4-PHENYL-6-(2,2,2-TRIFLUORO-1-PHENYLETHOXY)PYRIMIDINE-BASED COMPOUNDS | LEXICON PHARMACEUTICALS, INC. | 2009-03-05 | — | — | US | disclosed |
| US-20090062540-A1 | METHODS OF PREPARING 4-PHENYL-6-(2,2,2-TRIFLUORO-1-PHENYLETHOXY)PYRIMIDINE-BASED COMPOUNDS | LEXICON PHARMACEUTICALS, INC. | 2009-03-05 | — | — | US | disclosed |
| US-20090048280-A1 | Process for the preparation of substituted phenylalanines | TERSERA THERAPEUTICS LLC | 2009-02-19 | — | — | US | disclosed |
| US-20080280909-A1 | NEW PHENYLALANINE DERIVATIVES | AJINOMOTO CO., INC. (JP) | 2008-11-13 | — | — | US | disclosed |
| US-20080280909-A1 | NEW PHENYLALANINE DERIVATIVES | AJINOMOTO CO., INC. (JP) | 2008-11-13 | — | — | US | disclosed |
| US-7250516-B2 | Phenylalanine derivatives | AJINOMOTO CO., INC. (JP) | 2007-07-31 | — | — | US | disclosed |
| US-7250516-B2 | Phenylalanine derivatives | AJINOMOTO CO., INC. (JP) | 2007-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230348483-A1 | PREPARATION METHOD FOR (S)-2-AMINO-3-(4-(2,3-DIMETHYLPYRIDIN-4-YL)PHENYL)METHYL PROPIONATE DIACID SALT | SRD5A2, PKD2, SRM | AAK1 3248/4885KLK5 955/4885ITGB3 2914/4885 |
| US-20080280909-A1 | NEW PHENYLALANINE DERIVATIVES | ITGB4, VCAM1, ITGA4 | AAK1 2105/4885KLK5 1869/4885ITGB3 10/4885 |
| US-20090088447-A1 | SOLID FORMS OF (S)-ETHYL 2-AMINO-3-(4-(2-AMINO-6-((R)-1-(4-CHLORO-2-(3-METHYL-1H-PYRAZOL-1-YL)PHENYL)-2,2,2-TRIFLUOROETHOXY)-PYRIMIDIN-4-YL)PHENYL)PROPANOATE AND METHODS OF THEIR USE | CPS1, TUBA3C, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | AAK1 1734/4885KLK5 3401/4885ITGB3 1777/4885 |
| US-20230072397-A1 | Antimicrobial Compounds and Methods | MPO, NISCH, RPN2 | AAK1 2954/4885KLK5 843/4885ITGB3 4036/4885 |
| US-20090062540-A1 | METHODS OF PREPARING 4-PHENYL-6-(2,2,2-TRIFLUORO-1-PHENYLETHOXY)PYRIMIDINE-BASED COMPOUNDS | DPYD, TYMP, NUDT1 | AAK1 3075/4885KLK5 2934/4885ITGB3 4046/4885 |
| US-20230348390-A1 | METHOD FOR PREPARING METHYL(S)-2-AMINO-3-(4-(2,3-DIMETHYLPYRIDIN-4-YL)PHENYLPROPIONATE AND SALT THEREOF | SRM, KDM4B, DDC | AAK1 1716/4885KLK5 2562/4885ITGB3 4209/4885 |
| US-20090048280-A1 | Process for the preparation of substituted phenylalanines | PAH, TYR, NPEPPS | AAK1 2167/4885KLK5 2221/4885ITGB3 4703/4885 |
| US-20250381168-A1 | VLA4 INHIBITORS AND USES THEREOF | CXCR4, SDF4, ITGB4 | AAK1 1343/4885KLK5 2119/4885ITGB3 57/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.